0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sufentanil (API) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-12O6913
Home | Market Reports | Health| Pharmacy
Global Sufentanil API Market Insights and Forecast to 2028
BUY CHAPTERS

Global Sufentanil (API) Market Research Report 2025

Code: QYRE-Auto-12O6913
Report
September 2025
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sufentanil (API) Market Size

The global market for Sufentanil (API) was valued at US$ 355 million in the year 2024 and is projected to reach a revised size of US$ 555 million by 2031, growing at a CAGR of 6.7% during the forecast period.

Sufentanil (API) Market

Sufentanil (API) Market

Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine.
Sufentanil is a powerful analgesic drug with broad application prospects in the fields of medical services and drug therapy. In the next few years, the market size of sufentanil injection is expected to continue to expand and become an important pillar in the field of medical services and drug treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sufentanil (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sufentanil (API).
The Sufentanil (API) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sufentanil (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sufentanil (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sufentanil (API) Market Report

Report Metric Details
Report Name Sufentanil (API) Market
Accounted market size in year US$ 355 million
Forecasted market size in 2031 US$ 555 million
CAGR 6.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Purity 98%
  • Purity 99%
Segment by Application
  • Injection
  • Capsule
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Kern Pharma, Cambrex, Hameln Rds, Cristalia, Janssen Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sufentanil (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sufentanil (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Sufentanil (API) Market growing?

Ans: The Sufentanil (API) Market witnessing a CAGR of 6.7% during the forecast period 2025-2031.

What is the Sufentanil (API) Market size in 2031?

Ans: The Sufentanil (API) Market size in 2031 will be US$ 555 million.

Who are the main players in the Sufentanil (API) Market report?

Ans: The main players in the Sufentanil (API) Market are Kern Pharma, Cambrex, Hameln Rds, Cristalia, Janssen Pharmaceuticals

What are the Application segmentation covered in the Sufentanil (API) Market report?

Ans: The Applications covered in the Sufentanil (API) Market report are Injection, Capsule

What are the Type segmentation covered in the Sufentanil (API) Market report?

Ans: The Types covered in the Sufentanil (API) Market report are Purity 98%, Purity 99%

1 Sufentanil (API) Market Overview
1.1 Product Definition
1.2 Sufentanil (API) by Type
1.2.1 Global Sufentanil (API) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity 98%
1.2.3 Purity 99%
1.3 Sufentanil (API) by Application
1.3.1 Global Sufentanil (API) Market Value by Application (2024 VS 2031)
1.3.2 Injection
1.3.3 Capsule
1.4 Global Sufentanil (API) Market Size Estimates and Forecasts
1.4.1 Global Sufentanil (API) Revenue 2020-2031
1.4.2 Global Sufentanil (API) Sales 2020-2031
1.4.3 Global Sufentanil (API) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sufentanil (API) Market Competition by Manufacturers
2.1 Global Sufentanil (API) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sufentanil (API) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sufentanil (API) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sufentanil (API), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sufentanil (API), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sufentanil (API), Product Type & Application
2.7 Global Key Manufacturers of Sufentanil (API), Date of Enter into This Industry
2.8 Global Sufentanil (API) Market Competitive Situation and Trends
2.8.1 Global Sufentanil (API) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sufentanil (API) Players Market Share by Revenue
2.8.3 Global Sufentanil (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sufentanil (API) Market Scenario by Region
3.1 Global Sufentanil (API) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sufentanil (API) Sales by Region: 2020-2031
3.2.1 Global Sufentanil (API) Sales by Region: 2020-2025
3.2.2 Global Sufentanil (API) Sales by Region: 2026-2031
3.3 Global Sufentanil (API) Revenue by Region: 2020-2031
3.3.1 Global Sufentanil (API) Revenue by Region: 2020-2025
3.3.2 Global Sufentanil (API) Revenue by Region: 2026-2031
3.4 North America Sufentanil (API) Market Facts & Figures by Country
3.4.1 North America Sufentanil (API) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sufentanil (API) Sales by Country (2020-2031)
3.4.3 North America Sufentanil (API) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sufentanil (API) Market Facts & Figures by Country
3.5.1 Europe Sufentanil (API) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sufentanil (API) Sales by Country (2020-2031)
3.5.3 Europe Sufentanil (API) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sufentanil (API) Market Facts & Figures by Region
3.6.1 Asia Pacific Sufentanil (API) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sufentanil (API) Sales by Region (2020-2031)
3.6.3 Asia Pacific Sufentanil (API) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sufentanil (API) Market Facts & Figures by Country
3.7.1 Latin America Sufentanil (API) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sufentanil (API) Sales by Country (2020-2031)
3.7.3 Latin America Sufentanil (API) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sufentanil (API) Market Facts & Figures by Country
3.8.1 Middle East and Africa Sufentanil (API) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sufentanil (API) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sufentanil (API) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sufentanil (API) Sales by Type (2020-2031)
4.1.1 Global Sufentanil (API) Sales by Type (2020-2025)
4.1.2 Global Sufentanil (API) Sales by Type (2026-2031)
4.1.3 Global Sufentanil (API) Sales Market Share by Type (2020-2031)
4.2 Global Sufentanil (API) Revenue by Type (2020-2031)
4.2.1 Global Sufentanil (API) Revenue by Type (2020-2025)
4.2.2 Global Sufentanil (API) Revenue by Type (2026-2031)
4.2.3 Global Sufentanil (API) Revenue Market Share by Type (2020-2031)
4.3 Global Sufentanil (API) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sufentanil (API) Sales by Application (2020-2031)
5.1.1 Global Sufentanil (API) Sales by Application (2020-2025)
5.1.2 Global Sufentanil (API) Sales by Application (2026-2031)
5.1.3 Global Sufentanil (API) Sales Market Share by Application (2020-2031)
5.2 Global Sufentanil (API) Revenue by Application (2020-2031)
5.2.1 Global Sufentanil (API) Revenue by Application (2020-2025)
5.2.2 Global Sufentanil (API) Revenue by Application (2026-2031)
5.2.3 Global Sufentanil (API) Revenue Market Share by Application (2020-2031)
5.3 Global Sufentanil (API) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Kern Pharma
6.1.1 Kern Pharma Company Information
6.1.2 Kern Pharma Description and Business Overview
6.1.3 Kern Pharma Sufentanil (API) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Kern Pharma Sufentanil (API) Product Portfolio
6.1.5 Kern Pharma Recent Developments/Updates
6.2 Cambrex
6.2.1 Cambrex Company Information
6.2.2 Cambrex Description and Business Overview
6.2.3 Cambrex Sufentanil (API) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cambrex Sufentanil (API) Product Portfolio
6.2.5 Cambrex Recent Developments/Updates
6.3 Hameln Rds
6.3.1 Hameln Rds Company Information
6.3.2 Hameln Rds Description and Business Overview
6.3.3 Hameln Rds Sufentanil (API) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hameln Rds Sufentanil (API) Product Portfolio
6.3.5 Hameln Rds Recent Developments/Updates
6.4 Cristalia
6.4.1 Cristalia Company Information
6.4.2 Cristalia Description and Business Overview
6.4.3 Cristalia Sufentanil (API) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cristalia Sufentanil (API) Product Portfolio
6.4.5 Cristalia Recent Developments/Updates
6.5 Janssen Pharmaceuticals
6.5.1 Janssen Pharmaceuticals Company Information
6.5.2 Janssen Pharmaceuticals Description and Business Overview
6.5.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Janssen Pharmaceuticals Sufentanil (API) Product Portfolio
6.5.5 Janssen Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sufentanil (API) Industry Chain Analysis
7.2 Sufentanil (API) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sufentanil (API) Production Mode & Process Analysis
7.4 Sufentanil (API) Sales and Marketing
7.4.1 Sufentanil (API) Sales Channels
7.4.2 Sufentanil (API) Distributors
7.5 Sufentanil (API) Customer Analysis
8 Sufentanil (API) Market Dynamics
8.1 Sufentanil (API) Industry Trends
8.2 Sufentanil (API) Market Drivers
8.3 Sufentanil (API) Market Challenges
8.4 Sufentanil (API) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Sufentanil (API) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sufentanil (API) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sufentanil (API) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sufentanil (API) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Sufentanil (API) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sufentanil (API) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sufentanil (API) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sufentanil (API) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sufentanil (API), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sufentanil (API), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sufentanil (API), Product Type & Application
 Table 12. Global Key Manufacturers of Sufentanil (API), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sufentanil (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sufentanil (API) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sufentanil (API) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sufentanil (API) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Sufentanil (API) Sales Market Share by Region (2020-2025)
 Table 19. Global Sufentanil (API) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Sufentanil (API) Sales Market Share by Region (2026-2031)
 Table 21. Global Sufentanil (API) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sufentanil (API) Revenue Market Share by Region (2020-2025)
 Table 23. Global Sufentanil (API) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sufentanil (API) Revenue Market Share by Region (2026-2031)
 Table 25. North America Sufentanil (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sufentanil (API) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Sufentanil (API) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Sufentanil (API) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sufentanil (API) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sufentanil (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sufentanil (API) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Sufentanil (API) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Sufentanil (API) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sufentanil (API) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sufentanil (API) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sufentanil (API) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Sufentanil (API) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Sufentanil (API) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sufentanil (API) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sufentanil (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sufentanil (API) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Sufentanil (API) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Sufentanil (API) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sufentanil (API) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sufentanil (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sufentanil (API) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Sufentanil (API) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Sufentanil (API) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sufentanil (API) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sufentanil (API) Sales (K Units) by Type (2020-2025)
 Table 51. Global Sufentanil (API) Sales (K Units) by Type (2026-2031)
 Table 52. Global Sufentanil (API) Sales Market Share by Type (2020-2025)
 Table 53. Global Sufentanil (API) Sales Market Share by Type (2026-2031)
 Table 54. Global Sufentanil (API) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sufentanil (API) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sufentanil (API) Revenue Market Share by Type (2020-2025)
 Table 57. Global Sufentanil (API) Revenue Market Share by Type (2026-2031)
 Table 58. Global Sufentanil (API) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Sufentanil (API) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Sufentanil (API) Sales (K Units) by Application (2020-2025)
 Table 61. Global Sufentanil (API) Sales (K Units) by Application (2026-2031)
 Table 62. Global Sufentanil (API) Sales Market Share by Application (2020-2025)
 Table 63. Global Sufentanil (API) Sales Market Share by Application (2026-2031)
 Table 64. Global Sufentanil (API) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sufentanil (API) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sufentanil (API) Revenue Market Share by Application (2020-2025)
 Table 67. Global Sufentanil (API) Revenue Market Share by Application (2026-2031)
 Table 68. Global Sufentanil (API) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Sufentanil (API) Price (US$/Unit) by Application (2026-2031)
 Table 70. Kern Pharma Company Information
 Table 71. Kern Pharma Description and Business Overview
 Table 72. Kern Pharma Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Kern Pharma Sufentanil (API) Product
 Table 74. Kern Pharma Recent Developments/Updates
 Table 75. Cambrex Company Information
 Table 76. Cambrex Description and Business Overview
 Table 77. Cambrex Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Cambrex Sufentanil (API) Product
 Table 79. Cambrex Recent Developments/Updates
 Table 80. Hameln Rds Company Information
 Table 81. Hameln Rds Description and Business Overview
 Table 82. Hameln Rds Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hameln Rds Sufentanil (API) Product
 Table 84. Hameln Rds Recent Developments/Updates
 Table 85. Cristalia Company Information
 Table 86. Cristalia Description and Business Overview
 Table 87. Cristalia Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Cristalia Sufentanil (API) Product
 Table 89. Cristalia Recent Developments/Updates
 Table 90. Janssen Pharmaceuticals Company Information
 Table 91. Janssen Pharmaceuticals Description and Business Overview
 Table 92. Janssen Pharmaceuticals Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Janssen Pharmaceuticals Sufentanil (API) Product
 Table 94. Janssen Pharmaceuticals Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Sufentanil (API) Distributors List
 Table 98. Sufentanil (API) Customers List
 Table 99. Sufentanil (API) Market Trends
 Table 100. Sufentanil (API) Market Drivers
 Table 101. Sufentanil (API) Market Challenges
 Table 102. Sufentanil (API) Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sufentanil (API)
 Figure 2. Global Sufentanil (API) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sufentanil (API) Market Share by Type: 2024 & 2031
 Figure 4. Purity 98% Product Picture
 Figure 5. Purity 99% Product Picture
 Figure 6. Global Sufentanil (API) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Sufentanil (API) Market Share by Application: 2024 & 2031
 Figure 8. Injection
 Figure 9. Capsule
 Figure 10. Global Sufentanil (API) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Sufentanil (API) Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Sufentanil (API) Sales (2020-2031) & (K Units)
 Figure 13. Global Sufentanil (API) Average Price (US$/Unit) & (2020-2031)
 Figure 14. Sufentanil (API) Report Years Considered
 Figure 15. Sufentanil (API) Sales Share by Manufacturers in 2024
 Figure 16. Global Sufentanil (API) Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Sufentanil (API) Players: Market Share by Revenue in Sufentanil (API) in 2024
 Figure 18. Sufentanil (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Sufentanil (API) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Sufentanil (API) Sales Market Share by Country (2020-2031)
 Figure 21. North America Sufentanil (API) Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Sufentanil (API) Sales Market Share by Country (2020-2031)
 Figure 25. Europe Sufentanil (API) Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Sufentanil (API) Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Sufentanil (API) Revenue Market Share by Region (2020-2031)
 Figure 33. China Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Sufentanil (API) Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Sufentanil (API) Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Sufentanil (API) Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Sufentanil (API) Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Sufentanil (API) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Sufentanil (API) by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Sufentanil (API) by Type (2020-2031)
 Figure 55. Global Sufentanil (API) Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Sufentanil (API) by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Sufentanil (API) by Application (2020-2031)
 Figure 58. Global Sufentanil (API) Price (US$/Unit) by Application (2020-2031)
 Figure 59. Sufentanil (API) Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String